ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy (Q44846681)
Jump to navigation
Jump to search
scientific article published on 27 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy |
scientific article published on 27 January 2015 |
Statements
1 reference
ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy (English)
1 reference
1 reference
1 reference
Annegien Broeks
1 reference
Floris H Groenendijk
1 reference
Jeroen de Jong
1 reference
Elisabeth E Fransen van de Putte
1 reference
Andreas Schlicker
1 reference
Dennis Peters
1 reference
Marja Nieuwland
1 reference
Michel M van den Heuvel
1 reference
Ron M Kerkhoven
1 reference
Lodewijk F Wessels
1 reference
Bas W G van Rhijn
1 reference
Michiel S van der Heijden
1 reference
27 January 2015
1 reference
1 reference
69
1 reference
3
1 reference
384-388
1 reference